MET and colorectal neoplasm: Given the established suitability of c-Met as a marker for colorectal adenoma/adenocarcinoma detection [4, 11, 12, 25], and the prior validation of EMI-137 for imaging gastrointestinal (GI) malignancies [11, 12], this study aimed to post-operatively evaluate the topical application of EMI-137 for the visualisation of colorectal tumours.